tested targeting the mutant KRAS, using CRISPR-Cas9 in various cancer cell lines (SW403, SW480, SW680, HT29, LS513, LoVo) and analyzed its effect on cell proliferation, survival and cancer growth in vitro and in vivo [107]. The gene discussed is KRAS; the disease is cancer.